行业研究丨深度报告丨零售业 [Table_Title] 化妆品掘金增长系列：品类视角拆解竞争格局 %% %% %% %% research.95579.com 1 丨证券研究报告丨 报告要点 [Table_Summary] 我们认为对美妆竞争格局的判断，如细致拆解为品类和渠道，则可得出两方面结论：其一，对 于已建立领先优势的品牌，乳液面霜、面部精华为其品类基本盘，前者头部效应显著、后者更 易实现品类间连带；天猫为其渠道基本盘，在该渠道占据头部地位的品牌公司更易实现"强者 恒强"。其二，对于寻求增量、力求拓品类的品牌，抖音渠道尚处格局成长期，更易依托运营及 产品力实现排名突破。 分析师及联系人 [Table_Author] SAC：S0490514080004 SAC：S0490520080019 SFC：BUV258 请阅读最后评级说明和重要声明 2 / 20 %% %% %% %% research.95579.com 2 李锦 罗祎 曾维朵 [Table_Title2] 化妆品掘金增长系列：品类视角拆解竞争格局 [Table_Summary2] 总量：行业增速平稳，核心品类仍具国产化空间 护肤行业增速平稳 ...

大健康产业是关乎民生福祉、承载经济转型希望的新兴产业,也是聊城市重点打造的4条标志性产业链之 一。2025年以来,全市以《聊城市大健康产业发展规划(2024—2028年)》为蓝图,聚焦医药制品、健康食 品、医疗器械三大领域,将品牌建设作为核心引擎,着力推动产业链从"单点突破"向"集群协同"升级,从"传 统制造"向"高端智造"跨越。 目前,全市大健康产业链规上企业达52家,2025年实现产值114.5亿元,同比增长9.8%；营业收入102.7亿元, 同比增长6.2%；利润总额20.3亿元,同比增长13.2%,呈现出稳健向上的发展态势。特别值得一提的是,东 阿阿胶（000423）、冠县灵芝产业集群先后入选省级医养健康特色产业集群；全市大健康产业集群入选 省"十强产业"雁阵形产业集群储备库；聊城市参与联合申报的沿黄中医药产业集群入选省"十强产业"支 柱型雁阵集群,品牌赋能的叠加效应持续释放。 聊城市卫生健康委员会举行"品牌赋能大健康产业高质量融合发展"主题发布会,聊城市计划生育协会副 会长、大健康产业链专班办公室主任纪浩晴介绍了聊城市大健康产业链发展的有关情况。 陶春燕 聊城报道 构建品牌矩阵 筑牢产业发展"金招牌 ...

Core Viewpoint - The article highlights the journey of a Tibetan woman, Meduo, who is transforming the traditional craft of "Ada" into a modern skincare and cosmetic brand, while also promoting local employment and cultural heritage [4][5][6]. Group 1: Company Development - Meduo aims to establish a standardized factory for "Ada" production, which will include raw material processing, product development, and packaging, thereby reducing transportation costs and ensuring product quality [4]. - The company, Tibet Dezong Zuyu Industrial Development Co., Ltd., was founded in 2016, and it has evolved from a simple product to a diverse range of skincare and cosmetic offerings [9][10]. - The "Ada" series has expanded to include skincare sets, cosmetic products, and even calligraphy ink, with annual sales steadily increasing, establishing it as a representative brand of natural beauty products in Tibet [11]. Group 2: Market Strategy - Meduo has actively engaged in product innovation, transitioning from a single paste form to a multi-product matrix that includes skincare and makeup, while maintaining the traditional production methods [10]. - The company has leveraged online platforms and local exhibitions to promote its products, achieving a 40% share of online orders, with products reaching as far as Hainan [11]. - By collaborating with local e-commerce platforms and utilizing live demonstrations, the brand has effectively communicated the cultural significance and benefits of "Ada" to a broader audience [11]. Group 3: Community Impact - Meduo has implemented a training program for local women, providing them with skills in "Ada" production and creating job opportunities, with over 630 individuals trained to date [12]. - The company has established long-term agreements with local herders for yak milk procurement, ensuring quality raw materials while sharing the benefits of the industry with the community [13]. - Meduo also supports impoverished households in the region by providing financial assistance, reflecting a commitment to social responsibility and community upliftment [13].

Core Viewpoint - Fuhua Jia (301371) is a specialized skin care product company focused on the research, production, and sales of professional skin care products, which are divided into medical device products and functional skin care products [1] Group 1: Product Offerings - The company's product forms include masks, waters, serums, lotions, sprays, freeze-dried products, and single-use serums [1] Group 2: Sales Strategy - The company employs an omnichannel strategy for sales, integrating both online and offline channels [1] - Online channels include major e-commerce and social media platforms such as Tmall, Douyin, JD.com, and Pinduoduo [1] - Offline channels penetrate cosmetic specialty stores, large supermarkets, chain pharmacies, beauty institutions, and medical institutions, creating a comprehensive market reach network [1]

2月2日，水羊股份跌1.01%，成交额2.41亿元。两融数据显示，当日水羊股份获融资买入额2075.39万 元，融资偿还2223.87万元，融资净买入-148.48万元。截至2月2日，水羊股份融资融券余额合计3.89亿 元。 融资方面，水羊股份当日融资买入2075.39万元。当前融资余额3.89亿元，占流通市值的4.42%，融资余 额超过近一年70%分位水平，处于较高位。 融券方面，水羊股份2月2日融券偿还0.00股，融券卖出0.00股，按当日收盘价计算，卖出金额0.00元； 融券余量0.00股，融券余额0.00元，低于近一年10%分位水平，处于低位。 资料显示，水羊集团股份有限公司位于湖南省长沙市岳麓区谷苑路390号1栋综合楼101-1，成立日期 2012年11月1日，上市日期2018年2月8日，公司主营业务涉及从事化妆品的研发、生产与销售。主营业 务收入构成为：水乳膏霜81.84%，面膜17.32%，其他(补充)0.84%。 截至12月31日，水羊股份股东户数2.80万，较上期减少6.67%；人均流通股12820股，较上期增加 7.14%。2025年1月-9月，水羊股份实现营业收入34.09亿元，同比增长 ...

Group 1: AI Industry Insights - Baidu and Tencent are launching cash red envelope promotions to boost AI application usage during the Spring Festival, with Baidu offering 500 million yuan and Tencent 1 billion yuan in total rewards, potentially increasing AI application frequency across the industry [2] - The NAND flash memory prices have surged over 100% in Q1 2026, exceeding market expectations, as Samsung Electronics has completed supply contract negotiations, indicating a strong recovery in the storage industry [3] Group 2: Company Performance Forecasts - Sitway (688213.SH) expects 2025 revenue between 8.8 billion to 9.2 billion yuan, a year-on-year increase of 47% to 54%, with net profit projected at approximately 980 million to 1.03 billion yuan, reflecting a growth of 149% to 162% [4] - Bailong Chuangyuan reported a 2025 revenue of 1.379 billion yuan, up 19.75% year-on-year, and a net profit of 366 million yuan, up 48.94%, driven by product structure optimization and high-margin product prioritization [10] - Qingsong Co. forecasts 2025 revenue of about 2.22 billion yuan, a 14% increase, with net profit expected to grow 1.4 to 2 times, attributed to a strategic focus on high-margin cosmetics ODM business [11] - Rongjie Health anticipates a net profit of 75 to 88 million yuan in 2025, representing a growth of 60% to 88%, driven by the strong performance of health products, particularly high-margin infrared therapy sauna rooms [12]

Core Insights - The article discusses the growing trend of domestic beauty brands entering the OTC (over-the-counter) channel in China, with 2025 being marked as a pivotal year for this transition [2][3] - Major players like Proya and other beauty companies are preparing to launch products in the OTC space, which is seen as a way to leverage the professional credibility of pharmacies and meet specific skincare needs [4][5] Group 1: Market Entry and Growth - By 2025, over six domestic cosmetic companies are expected to enter the OTC channel, expanding the current limited presence of leading brands [2] - Proya announced its entry into the OTC channel in January 2026, joining other brands that have already established a presence [2][4] - The OTC channel has seen significant sales, with brands like Winona achieving nearly 1 billion yuan in sales from this channel in 2023 [3] Group 2: Strategic Partnerships and Product Development - Companies are focusing on strategic partnerships and product development tailored for the OTC market, with Proya preparing multiple products aimed at post-operative recovery and daily skincare [4] - Winona and other brands are actively seeking to enhance their product offerings and market reach through collaborations with pharmacies [3][4] Group 3: Market Potential and Challenges - The OTC channel is projected to have about double the growth potential, with Winona aiming to cover 250,000 pharmacies [5] - The regulatory environment is becoming more favorable for pharmacies to sell cosmetic products, which aligns with the increasing demand for beauty products in these settings [6] - Despite the opportunities, there is a significant talent shortage in the OTC channel, as brands require personnel who are knowledgeable in both pharmaceuticals and cosmetics [7] Group 4: Financial Metrics and Profitability - The average gross margin for medical beauty products in the OTC channel is significantly higher than that of regular cosmetic products, with margins for medical dressings ranging from 77% to 83% [6] - Specific companies report high gross margins, such as 84.22% for Chuerjia's medical device products and 82% for Jinjian Biological's collagen products [6]

Group 1: SpaceX IPO Plans - SpaceX, led by Elon Musk, aims to complete its IPO by July this year, moving up from previous expectations of a 2026 listing [2] - The company was valued at $800 billion during a secondary market share sale in December last year [2] Group 2: Vanke Debt Restructuring - Vanke has successfully passed a key proposal for debt extension, allowing it to pay 40% of the principal on its domestic bond "21 Vanke 02" and extend the remaining 60% for one year [2] - The proposal received overwhelming support with a 92.11% approval rate, marking a significant step in alleviating Vanke's liquidity pressures [2] - Despite this progress, Vanke still faces over 10 billion in maturing debts this year, indicating that its recovery efforts are just beginning [2] Group 3: Suiyuan Technology IPO Acceptance - Suiyuan Technology has had its IPO application accepted by the Shanghai Stock Exchange, becoming the first company to be accepted for the Sci-Tech Innovation Board in 2026 [4] - The company focuses on cloud AI chips and has developed four generations of architecture and five chip models, indicating a strong position in the domestic AI chip market [4]

Core Viewpoint - Qingsong Co., Ltd. (青松股份) expects significant growth in its 2025 performance, with projected revenue and net profit showing substantial year-on-year increases [4]. Financial Performance - The company anticipates a revenue of 2.218 billion yuan in 2025, representing a year-on-year growth of 14.34% [4]. - The expected net profit attributable to shareholders is between 130 million yuan and 165 million yuan, indicating a year-on-year increase of 137.73% to 201.74% [4]. - The forecasted net profit excluding non-recurring items is estimated to be between 96 million yuan and 131 million yuan, reflecting a growth of 73.29% to 136.47% year-on-year [4]. Valuation Metrics - As of January 22, the company's price-to-earnings ratio (TTM) is approximately between 29.05 and 36.88 times, with a price-to-book ratio (LF) of about 3.4 times and a price-to-sales ratio (TTM) of around 2.16 times [4]. - Historical price-to-earnings ratio trends indicate fluctuations over recent years, with the company’s TTM P/E ratio showing a range from 20 to 41 times [5][6]. Industry Context - The overall consumption in the domestic cosmetics industry is experiencing a steady recovery, which has positively impacted customer order demand for the company [13]. - The company’s performance improvement is also attributed to the completion of a land project disposal, which is expected to contribute approximately 34 million yuan to the net profit [13].

Investment Rating - The report assigns a "Buy" rating to the company with a current price of 8.70 CNY and a fair value of 10.50 CNY [2]. Core Insights - The company, Qingsong Co., Ltd., has transitioned to focus on the cosmetics ODM sector, with a significant recovery in profitability expected as operational efficiencies improve and customer orders rebound [10]. - The company has undergone a strategic shift by divesting its turpentine business and acquiring 100% of the cosmetics OEM leader, Norsbel, enhancing its competitive position in the cosmetics manufacturing industry [15][16]. - The report forecasts a positive trend in revenue and net profit, with expected net profits of 1.3 billion CNY in 2025, 1.8 billion CNY in 2026, and 2.3 billion CNY in 2027, supported by a robust customer base and product focus [10]. Summary by Sections Company Overview - Qingsong Co., Ltd. has evolved from a turpentine producer to a leading player in the cosmetics ODM market, acquiring Norsbel to strengthen its business model [15]. - The company has faced challenges due to the pandemic and regulatory pressures but is now on a recovery path with improved operational efficiency [16]. Financial Analysis - The company reported revenues of 19.69 billion CNY in 2023, with a projected slight decline to 19.40 billion CNY in 2024, followed by a recovery to 21.11 billion CNY in 2025 [9][27]. - The net profit is expected to turn positive in 2024, with significant growth projected in subsequent years, reflecting a recovery from previous losses [10][27]. Industry Analysis - The global beauty and personal care market is projected to grow to 651.6 billion USD by 2024, with a steady recovery anticipated in the cosmetics sector [43]. - The Chinese cosmetics market is expected to reach 73.7 billion USD by 2025, indicating a shift towards stable growth as the industry matures [46]. - Regulatory changes are expected to benefit compliant companies, leading to increased market concentration and the exit of non-compliant players [51]. Strategic Focus - The company is concentrating on high-value product categories, particularly facial masks, and aims to enhance its customer base by focusing on key clients [10]. - The operational strategy includes optimizing product offerings and improving supply chain efficiency, which is expected to enhance profitability and market share [10].